Literature DB >> 4055788

Glycosyl-sn-1,2-dimyristylphosphatidylinositol is covalently linked to Trypanosoma brucei variant surface glycoprotein.

M A Ferguson, M G Low, G A Cross.   

Abstract

The COOH terminus of the externally disposed variant surface glycoprotein (VSG) of the eukaryotic pathogenic protozoan Trypanosoma brucei strain 427 variant MITat 1.4 (117) is covalently linked to a novel phosphatidylinositol-containing glycolipid. This conclusion is supported by analysis of the products of nitrous acid deamination or Staphylococcus aureus phosphatidylinositol-specific phospholipase C treatment of purified membrane-form VSG. Lysis of trypanosomes is accompanied by release of soluble VSG, catalyzed by activation of an endogenous phospholipase C. The only apparent difference between membrane-form VSG and soluble VSG is the removal of sn-1,2-dimyristylglycerol. The COOH-terminal glycopeptide derived by Pronase digestion of soluble VSG was characterized by chemical modification and digestion with alkaline phosphatase. The results are consistent with the single non-N-acetylated glucosamine residue being the reducing terminus of the oligosaccharide and in a glycosidic linkage to a myo-inositol monophosphate that is probably myo-inositol 1,2-cyclic monophosphate. A partial structure for the VSG COOH-terminal moiety is presented. This structure represents a new type of eukaryotic post-translational protein modification and membrane anchor. We discuss the relevance of this structure to observations that have been made with other eukaryotic membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055788

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis.

Authors:  K L Lohman; P J Langer; D McMahon-Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Phosphatidylinositol 4,5-bisphosphate is selectively retained by platelet-fibrin clots formed by thrombin.

Authors:  J D Vickers; R L Kinlough-Rathbone; J F Mustard
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

3.  Renal dipeptidase is one of the membrane proteins released by phosphatidylinositol-specific phospholipase C.

Authors:  N M Hooper; M G Low; A J Turner
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

4.  Characterization of the phosphatidylinositol-glycan membrane anchor of human placental alkaline phosphatase.

Authors:  A D Howard; J Berger; L Gerber; P Familletti; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 5.  Acylation in trypanosomatids: an essential process and potential drug target.

Authors:  Amanda M Goldston; Aabha I Sharma; Kimberly S Paul; David M Engman
Journal:  Trends Parasitol       Date:  2014-06-19

6.  Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells.

Authors:  G Romero; G Gámez; L C Huang; K Lilley; L Luttrell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 7.  Emerging functional roles for the glycosyl-phosphatidylinositol membrane protein anchor.

Authors:  M P Lisanti; E Rodriguez-Boulan; A R Saltiel
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

8.  Cloning and functional expression of glycosyltransferases from parasitic protozoans by heterologous complementation in yeast: the dolichol phosphate mannose synthase from Trypanosoma brucei brucei.

Authors:  R Mazhari-Tabrizi; V Eckert; M Blank; R Müller; D Mumberg; M Funk; R T Schwarz
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

9.  Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol.

Authors:  K Haldar; C L Henderson; G A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.

Authors:  Terry K Smith; Benjamin L Young; Helen Denton; David L Hughes; Gerd K Wagner
Journal:  Bioorg Med Chem Lett       Date:  2009-01-30       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.